Kevin Richardson
In a stunning breakthrough that could redefine cancer treatment, scientists in China have developed an innovative therapy that disguises cancerous tumor to pork tissue—successfully triggering the immune system to attack and destroy them.
This pioneering technique, dubbed the “tumor to pork” strategy, has shown remarkable results in early clinical trials, achieving over a 90% success rate.
The research team, led by Professor Zhao Yongxiang at Guangxi Medical University, utilized a harmless virus known as Newcastle Disease Virus (NDV). This virus is genetically modified to carry pig tissue genes, tricking the human immune system into launching an intense response, similar to the rejection process seen in failed organ transplants.
Unlike traditional treatments like chemotherapy or radiation, which can harm healthy cells and come with severe side effects, this new method takes a more targeted approach by empowering the body’s natural defenses. When the engineered virus is introduced into a patient’s system, it “flags” the tumor as foreign—specifically, as non-human pig tissue—sparking a robust immune reaction that attacks and breaks down the cancer cells.
Tumor to pork therapy
In a recent study involving 23 patients suffering from advanced-stage cancers—including cervical, liver, ovarian, and lung—weekly infusions of the modified virus led to dramatic tumor shrinkage or even complete remission in most cases. Even more promising, the side effects reported were minimal compared to conventional therapies.
“These results are very encouraging,” said Professor Zhao. “By using the body’s own immune system in a highly specific way, we may have found a safer and more effective way to target some of the most difficult-to-treat cancers.”
The approach is currently progressing through Phase 2 and 3 clinical trials, with the goal of expanding the treatment to a larger population. If successful, it could signal a major shift in how doctors approach cancer therapy—offering an alternative to invasive treatments with broader applicability to various types of cancer.
Medical experts worldwide are closely watching the development of this therapy, which not only pushes the boundaries of immunotherapy but also offers renewed hope for patients battling treatment-resistant tumors.
As the global medical community continues to pursue less invasive and more personalized cancer treatments, this tumor-to-pork method may one day be regarded as a milestone in the fight against cancer.
Read more: Scientists Just Grew Human Teeth In a Lab For The First Time Ever
